Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03234088 · ClinicalTrials.gov registry record · NA

Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring

A NA study of Congestive Heart Failure, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT03234088 is a NA study of Congestive Heart Failure that has completed, run by University of Pennsylvania. The registered enrollment target is 13 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03234088, a NA study of Congestive Heart Failure, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

As the population ages and medicine advances, there has been a significant shift to the management of chronic diseases. Most chronic diseases are managed using evidence based consensus guidelines but clinician and patient compliance with these guidelines is sub-optimal. In addition, due to the nature of chronic diseases, patients need to make long-term lifestyle changes in order to effectively control their disease in order to minimize complications, disability and cost. It is these two factors, consistent implementation of evidence-based guidelines and supporting patients in a way that encourages self-management and lifestyle change, that disease management attempts to impact. There are areas of design, implementation, testing and final-result-reporting to the patient and clinician that require collaboration among information technology (IT) and software design engineers and clinicians to achieve several goals: 1. Ensure patient safety. 2. Protect the security and integrity of clinical data. 3. Provide patient specific education to promote self-management. 4. Provide actionable data to clinicians in order to improve clinical care and minimize the risk of adverse events. 5. Provide both patient and clinician satisfaction with the system of care. In order to achieve these goals, testing and development of home technology under a controlled clinical trial is critical.

Conditions Studied

Interventions

  • BEHAVIORAL Daily weight measured by digital scale and symptom reporting

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2011-04
Est. Completion 2012-08
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03234088

The ClinicalTrials.gov registry entry for NCT03234088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (96% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Daily weight measured by digital scale and symptom reporting is the first listed.

NCT03234088 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03234088 about?

NCT03234088 is a clinical study titled "Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring". As the population ages and medicine advances, there has been a significant shift to the management of chronic diseases. Most chronic diseases are managed using evidence based consensus guidelines but clinician and patient compliance with these guidelines is sub-optimal. In addition, due to the natur...

What is the current status of trial NCT03234088?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2011-04. Estimated completion is 2012-08.

What conditions does trial NCT03234088 study?

This clinical trial studies the following conditions: Congestive Heart Failure.

What interventions are being tested in trial NCT03234088?

The interventions under investigation include: Daily weight measured by digital scale and symptom reporting (BEHAVIORAL).

Who is sponsoring clinical trial NCT03234088?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03234088 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congestive Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.